Product
Smoflipid
2 clinical trials
3 indications
Indication
MalnutritionIndication
PediatricClinical trial
Prospective, Randomized (1:1), Double-Blind, Parallel-Group, Active-Controlled, Multicenter Study to Compare Safety and Efficacy of Smoflipid to Intralipid 20% in Pediatric Patients of 3 Months to 16 Years of Age Requiring Parenteral Nutrition for at Least 90 Days and up to 1 YearStatus: Terminated, Estimated PCD: 2020-11-12
Clinical trial
Comparison of Composite Lipid Emulsion Containing Fish Oil to Soy-based Lipid Reduction for Cholestasis Prevention in Neonates Requiring Abdominal SurgeryStatus: Active (not recruiting), Estimated PCD: 2021-03-28